Lipella completes final close of Series B offering ($88.5K) and launches March warrant offering

LIPELLA PHARMACEUTICALS INC.

Final close sold 885 shares of Series B preferred at $100/share for $88,500 gross; net proceeds $73,455.
Warrant offering: up to 60,000 warrants at $0.125 each, each exercisable for 1 Series B share ($100) convertible at $2.16.
Placement agent Spartan receives $15,045 fees, 10,326 Series C preferred shares, and warrants for 4,060 common shares.
Registration rights require filing within 30 days; failure triggers 100,000 common shares or cash penalty monthly.
Proceeds from both offerings intended for working capital and general corporate purposes.

item 1.01 item 3.02 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001753926-25-000467
form_type: 8-K
ticker: LIPO
cik: 0001347242
company_name: LIPELLA PHARMACEUTICALS INC.
filed_at: 2025-03-18T23:59:59+00:00
discovered_at: 2026-05-14T18:03:03.406031+00:00
generated_at: 2026-05-24T13:23:04.622554+00:00
sec_items: ["1.01", "3.02", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.65
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001753926-25-000467
json_url: https://secwatch.observer/filing/0001753926-25-000467.json
markdown_url: https://secwatch.observer/filing/0001753926-25-000467.md
text_url: https://secwatch.observer/filing/0001753926-25-000467.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1347242/000175392625000467/0001753926-25-000467-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1347242/000175392625000467/g084733_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001753926-25-000467

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.